首页|德谷胰岛素联合艾托格列净治疗老年T2DM的效果

德谷胰岛素联合艾托格列净治疗老年T2DM的效果

扫码查看
目的 探讨德谷胰岛素联合艾托格列净治疗老年2型糖尿病(T2DM)患者的效果.方法 选取2023年1月至12月我院收治的82例老年T2DM患者,根据治疗方式的不同分为两组.对照组采用门冬胰岛素治疗,观察组采用德谷胰岛素联合艾托格列净治疗.比较两组的血糖、血压及不良反应.结果 治疗后,观察组的HbA1c、MAGE、血糖CV值均低于对照组,SBP、DBP均低于对照组(P<0.05).观察组的不良反应发生率为7.32%,低于对照组的24.39%(P<0.05).结论 德谷胰岛素联合艾托格列净治疗老年T2DM具有显著的降糖及降压效果,且安全性较高.
Effect of Insulin Degludec Combined with Ertugliflozin in the Treatment of Elderly Patients with T2DM
Objective To explore the effect of insulin degludec combined with ertugliflozin in the treatment of elderly patients with type 2 diabetes mellitus(T2DM).Methods 82 elderly patients with T2DM admitted to our hospital from January 2023 to December 2023 were selected and divided into two groups according to different treatment methods.The control group was treated with insulin aspart,and the observation group was treated with insulin degludec combined with ertugliflozin.The blood glucose,blood pressure and adverse reactions were compared between the two groups.Results After treatment,HbAlc,MAGE and blood glucose CV value in the observation group were lower than those in the control group,and SBP and DBP were lower than those in the control group(P<0.05).The incidence of adverse reactions in the observation group was 7.32%,lower than 24.39%in the control group(P<0.05).Conclusions Insulin degludec combined with ertugliflozin in the treatment of elderlv T2DM has significant hvpoglvcemic and antihypertensive effects,and has high safetv.

Insulin degludecErtugliflozinElderlyType 2 diabetes mellitusBlood glucoseBlood pressureAdverse reaction

郑宇、吴敬

展开 >

商丘市中心医院内分泌科,河南商丘 476000

德谷胰岛素 艾托格列净 老年 2型糖尿病 血糖 血压 不良反应

河南省医学科技攻关计划联合共建项目

LHGJ20191506

2024

临床医学工程
国家医疗保健器具工程技术研究中心

临床医学工程

影响因子:0.193
ISSN:1674-4659
年,卷(期):2024.31(10)